Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice

Allele- and temperature-dependency of in vitro HLA class I assembly

Allelic variations of in vitro HLA class I assembly have been investigated in both the absence and the presence of binding peptides by flow cytometry using human leukocyte antigen (HLA) class I alpha chains isolated by alkali treatment from cultured HLA homozygous B cells and polystyrene beads coated with anti-HLA class I alpha chain antibodies specific to the C-terminal segment (anti-HLA class I beads). The specificity of assembly was temperature dependent, while the stability of the assembled complex depended on the bound peptide. The efficiency of assembly was allele dependent and primarily ruled by the binding affinity of alpha chains with beta(2)m. Thus, an allele hierarchy could be defined for the binding of HLA-B alpha chain with beta(2)-microglobulin: B7, B18 > B35, B62 > B27, B51. Allele and temperature dependency was found in HLA class I reassembly on acid treated B cells. The HLA class I proteins, reassembled with specific single peptides, could be efficiently transferred to anti-HLA class I beads. These findings would be used to produce microspheres coupled at high surface density with oriented single-peptide loaded HLA class I molecules and also to improve the preparation efficiency of HLA class I tetramers by the use of site-specific biotinylation.

The use of human leucocyte antigen class I transgenic mice to investigate human immune function

HLA class I transgenic mice are a powerful research tool which have been used as models for human immune responses. This review describes the generation of the different HLA class I transgenic mice, the techniques used to improve expression of the transgene and use of the transgene product in immune responses. It also illustrates how HLA class I transgenic mice have provided insights into the nature of the allogeneic and xenogeneic response, the generation of CTL responses, the development of autoimmune diseases, and their use for the generation of anti-HLA class I antibodies. Despite these advances, the use of available HLA class I transgenic mice as models for human disease and immune responses has been limited. The development of new transgenic strains incorporating multiple human transgenes may allow the potential of HLA class I transgenic mice to be realised.

Conversion of a human immunodeficiency virus cytotoxic T lymphocyte epitope into a high affinity HLA-Cw3 ligand

To elucidate the residues important for the binding of peptides to HLA-Cw3, a substitutional analysis of two HLA-Cw*0304-binding peptides was performed. The optimal registry and length for a Cw3-restricted epitope from HIV-1 p24gag was determined to be a nonamer, p24gag 144-152. Substituted analogs of this nonamer peptide revealed that substitutions at position 3 (P3) and the carboxyl-terminal P9 were inhibitory to binding, while certain substitutions at the amino-terminal P1 or P2 increased binding significantly. Substituted analogs of another Cw3-restricted peptide, the Cw3 consensus peptide, which binds to HLA-Cw*0304 with a 1,000-fold higher affinity and with a greater stability than the HIV p24gag nonamer revealed that the P1, P2, P6, and P9 residues play important roles in the ligand's binding to Cw*0304. The incorporation of the amino-terminal P1 and P2 residues from the Cw3 consensus peptide into the HIV p24gag 144-152 peptide created a hybrid peptide with profoundly enhanced affinity for and stability with Cw*0304. Collectively, these findings provide a clear insight into how peptides interact with HLA-Cw3 and how high affinity Cw3 ligands can be constructed.